Concord Medical Services Stock Price, News & Analysis (NYSE:CCM)

Concord Medical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "CCM."

Concord Medical Services Hldg Ltd (NYSE:CCM) issued its quarterly earnings results on Wednesday, August, 24th. The company reported ($0.06) EPS for the quarter, missing the consensus estimate of $0.21 by $0.27. The company had revenue of $18.93 million for the quarter. View Concord Medical Services' Earnings History.

News coverage about CCM stock has been trending somewhat positive on Saturday, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Concord Medical Services earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Concord Medical Services.

Concord Medical Services saw a increase in short interest during the month of September. As of September 30th, there was short interest totalling 3,400 shares, an increase of 21.4% from the August 30th total of 2,800 shares. Based on an average daily trading volume, of 5,200 shares, the short-interest ratio is presently 0.7 days. Approximately 0.0% of the company's stock are short sold. View Concord Medical Services' Current Options Chain.

Some companies that are related to Concord Medical Services include Oxford BioMedica (OXB), Avedro (AVDR), Crinetics Pharmaceuticals (CRNX), TELIX Pharmaceutical (TLX), Bellus Health (BLU), Frequency Therapeutics (FREQ), Synthorx (THOR), Stemline Therapeutics (STML), Beyondspring (BYSI), Surgery Partners (SGRY), SI-Bone (SIBN), AMAG Pharmaceuticals (AMAG), Assembly Biosciences (ASMB), Collegium Pharmaceutical (COLL) and Establishment Labs (ESTA).

Based on aggregate information from My MarketBeat watchlists, some companies that other Concord Medical Services investors own include Hi-Crush Partners (HCLP), The Carlyle Group (CG), Fibrocell Science (FCSC), Laurentian Bank of Canada (LB), NovaBay Pharmaceuticals (NBY), Arbutus Biopharma (ABUS), Biocept (BIOC), BofI (BOFI), Avid Bioservices (CDMO) and Corcept Therapeutics (CORT).

Concord Medical Services' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Wedbush Securities Inc. (0.02%).

CCM stock was sold by a variety of institutional investors in the last quarter, including Wedbush Securities Inc..

Shares of CCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CCM stock can currently be purchased for approximately $2.29.

Concord Medical Services has a market capitalization of $99.29 million and generates $27.76 million in revenue each year. The company earns $-34,160,000.00 in net income (profit) each year or ($1.20) on an earnings per share basis. Concord Medical Services employs 583 workers across the globe.View Additional Information About Concord Medical Services.

The official website for Concord Medical Services is http://www.concordmedical.com/.

Concord Medical Services' mailing address is 18/F TOWER A GLOBAL TRADE CENTER 36 NORTH THIRD RING ROAD, BEIJING F4, 100013. The company can be reached via phone at 86-10-5903-6688 or via email at [email protected]